Skip to main content
Top
Published in: International Urology and Nephrology 2/2014

01-02-2014 | Nephrology - Original Paper

Outcomes of dialytic modalities in a large incident registry cohort from Eastern Europe: the Romanian Renal Registry

Authors: Gabriel Mircescu, Gabriel Ştefan, Liliana Gârneaţă, Irina Mititiuc, Dimitrie Siriopol, Adrian Covic

Published in: International Urology and Nephrology | Issue 2/2014

Login to get access

Abstract

Background

Studies comparing survival in hemodialysis (HD) or peritoneal dialysis (PD) patients reported controversial results, mainly during the first 2 years of treatment. Moreover, there is a significant geographic variation in the use of these modalities. We aimed to compare the survival of HD and PD patients using data from the Romanian Renal Registry.

Methods

In an intention-to-treat analysis using Kaplan–Meier and Cox proportional hazard (CPH) models, survival was compared between 8,252 incident HD patients and 1,000 incident PD patients treated between 2008 and 2011. The patients were followed from the dialysis initiation and stratified by modality on day 90. The time on dialysis was separated into four periods (3–12, 12–24, 24–36 and >36 months), and outcome comparisons were made.

Results

Mean survival time was 46.3 (44.9–47.6) months in PD group and 45.8 (45.3–46.3) months in HD group (p = 0.9, log-rank test). In the multivariate CPH models, age, diabetes-associated kidney disease (DM), primary renal disease and center size significantly influenced survival. In the first year of therapy, the mortality was higher in HD than in PD patients (HR = 1.34 (1.12–1.60), p = 0.001), while in the second and third year, HD patients survived better (HR = 0.69 (0.53–0.89), p = 0.005); HR = 0.56 (0.41–0.78), p = 0.001) and after 36 months, the survival difference was not statistically significant (HR = 0.63 (0.34–1.13), p = 0.1), respectively.

Conclusions

Despite the survival advantage for PD patients during the first year and that of HD in the next 2 years of dialysis, the overall survival in HD and PD patients was similar and was influenced by age, DM and center size.
Footnotes
1
www.​recensamantroman​ia.​ro (REZULTATE DEFINITIVE RPL 2011).
 
2
Romanian Renal Registry Report 2012.
 
Literature
1.
go back to reference van de Luijtgaarden MW, Jager KJ, Stel VS, Kramer A, Cusumano A, Elliott RF, Geue C, MacLeod AM, Stengel B, Covic A, Caskey FJ (2013) Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 28(5):1264–1275. doi:10.1093/ndt/gft053 van de Luijtgaarden MW, Jager KJ, Stel VS, Kramer A, Cusumano A, Elliott RF, Geue C, MacLeod AM, Stengel B, Covic A, Caskey FJ (2013) Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 28(5):1264–1275. doi:10.​1093/​ndt/​gft053
2.
go back to reference ERA–EDTA Registry: ERA–EDTA registry annual report 2010 (2012). Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands ERA–EDTA Registry: ERA–EDTA registry annual report 2010 (2012). Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands
3.
go back to reference Murphy SW, Foley RN, Barrett BJ, Kent GM, Morgan J, Barre P, Campbell P, Fine A, Goldstein MB, Handa SP, Jindal KK, Levin A, Mandin H, Muirhead N, Richardson RM, Parfrey PS (2000) Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 57(4):1720–1726. doi:10.1046/j.1523-1755.2000.00017.x PubMedCrossRef Murphy SW, Foley RN, Barrett BJ, Kent GM, Morgan J, Barre P, Campbell P, Fine A, Goldstein MB, Handa SP, Jindal KK, Levin A, Mandin H, Muirhead N, Richardson RM, Parfrey PS (2000) Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 57(4):1720–1726. doi:10.​1046/​j.​1523-1755.​2000.​00017.​x PubMedCrossRef
4.
go back to reference Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT, Netherlands Cooperative Study on the Adequacy of Dialysis Study G (2003) Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol JASN 14(11):2851–2860CrossRef Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT, Netherlands Cooperative Study on the Adequacy of Dialysis Study G (2003) Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol JASN 14(11):2851–2860CrossRef
7.
go back to reference Vonesh EF, Moran J (1999) Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol JASN 10(2):354–365 Vonesh EF, Moran J (1999) Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol JASN 10(2):354–365
8.
go back to reference Heaf JG, Lokkegaard H, Madsen M (2002) Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 17(1):112–117 Heaf JG, Lokkegaard H, Madsen M (2002) Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 17(1):112–117
10.
go back to reference Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, Krediet RT, Group NS (2003) Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 64(6):2222–2228. doi:10.1046/j.1523-1755.2003.00321.x PubMedCrossRef Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, Krediet RT, Group NS (2003) Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 64(6):2222–2228. doi:10.​1046/​j.​1523-1755.​2003.​00321.​x PubMedCrossRef
12.
go back to reference Romanian Renal Registry (2011) ‘Dr Carol Davila’. Teaching Hospital of Nephrology, Bucharest, Romania Romanian Renal Registry (2011) ‘Dr Carol Davila’. Teaching Hospital of Nephrology, Bucharest, Romania
13.
go back to reference Horl WH, de Alvaro F, Williams PF (1999) Healthcare systems and end-stage renal disease (ESRD) therapies–an international review: access to ESRD treatments. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 14(Suppl 6):10–15 Horl WH, de Alvaro F, Williams PF (1999) Healthcare systems and end-stage renal disease (ESRD) therapies–an international review: access to ESRD treatments. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 14(Suppl 6):10–15
14.
go back to reference De Vecchi AF, Dratwa M, Wiedemann ME (1999) Healthcare systems and end-stage renal disease (ESRD) therapies–an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 14(Suppl 6):31–41 De Vecchi AF, Dratwa M, Wiedemann ME (1999) Healthcare systems and end-stage renal disease (ESRD) therapies–an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 14(Suppl 6):31–41
15.
go back to reference Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Ding S, Guo H, Kats A, Lamb K, Li S, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2013) US renal data system 2012 annual data report. Am J Kidney Dis Off J Natl Kidney Found 61(1 Suppl 1): A7, e1–476. doi:10.1053/j.ajkd.2012.11.031 Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Ding S, Guo H, Kats A, Lamb K, Li S, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2013) US renal data system 2012 annual data report. Am J Kidney Dis Off J Natl Kidney Found 61(1 Suppl 1): A7, e1–476. doi:10.​1053/​j.​ajkd.​2012.​11.​031
16.
go back to reference Sanabria M, Munoz J, Trillos C, Hernandez G, Latorre C, Diaz CS, Murad S, Rodriguez K, Rivera A, Amador A, Ardila F, Caicedo A, Camargo D, Diaz A, Gonzalez J, Leguizamon H, Lopera P, Marin L, Nieto I, Vargas E (2008) Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl 108:S165–S172. doi:10.1038/sj.ki.5002619 PubMedCrossRef Sanabria M, Munoz J, Trillos C, Hernandez G, Latorre C, Diaz CS, Murad S, Rodriguez K, Rivera A, Amador A, Ardila F, Caicedo A, Camargo D, Diaz A, Gonzalez J, Leguizamon H, Lopera P, Marin L, Nieto I, Vargas E (2008) Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl 108:S165–S172. doi:10.​1038/​sj.​ki.​5002619 PubMedCrossRef
18.
go back to reference Kramer A, Stel VS, Caskey FJ, Stengel B, Elliott RF, Covic A, Geue C, Cusumano A, Macleod AM, Jager KJ (2012) Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol CJASN 7(10):1655–1663. doi:10.2215/CJN.10461011 CrossRef Kramer A, Stel VS, Caskey FJ, Stengel B, Elliott RF, Covic A, Geue C, Cusumano A, Macleod AM, Jager KJ (2012) Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol CJASN 7(10):1655–1663. doi:10.​2215/​CJN.​10461011 CrossRef
19.
go back to reference Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ (2011) Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 26(8):2604–2610. doi:10.1093/ndt/gfq781 Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ (2011) Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 26(8):2604–2610. doi:10.​1093/​ndt/​gfq781
20.
go back to reference Mircescu G, Garneata L, Florea L, Cepoi V, Capsa D, Covic M, Gherman-Caprioara M, Gluhovschi G, Golea OS, Barbulescu C, Rus E, Santimbrean C, Mardare N, Covic A (2006) The success story of peritoneal dialysis in Romania: analysis of differences in mortality by dialysis modality and influence of risk factors in a national cohort. Perit Dial Int J Int Soc Perit Dial 26(2):266–275 Mircescu G, Garneata L, Florea L, Cepoi V, Capsa D, Covic M, Gherman-Caprioara M, Gluhovschi G, Golea OS, Barbulescu C, Rus E, Santimbrean C, Mardare N, Covic A (2006) The success story of peritoneal dialysis in Romania: analysis of differences in mortality by dialysis modality and influence of risk factors in a national cohort. Perit Dial Int J Int Soc Perit Dial 26(2):266–275
21.
go back to reference Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S (2012) Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 27(9):3568–3575. doi:10.1093/ndt/gfr674 Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S (2012) Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 27(9):3568–3575. doi:10.​1093/​ndt/​gfr674
22.
go back to reference Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, Jeffery JR, Kjellstrand CM (1997) Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis Off J Natl Kidney Found 30(3):334–342CrossRef Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, Jeffery JR, Kjellstrand CM (1997) Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis Off J Natl Kidney Found 30(3):334–342CrossRef
23.
go back to reference Huang CC, Cheng KF, Wu HD (2008) Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int J Int Soc Perit Dial 28(Suppl 3):S15–S20 Huang CC, Cheng KF, Wu HD (2008) Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int J Int Soc Perit Dial 28(Suppl 3):S15–S20
24.
go back to reference van der Wal WM, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, Geskus RB (2010) Comparing mortality in renal patients on hemodialysis versus peritoneal dialysis using a marginal structural model. Int J Biostat 6(1):Article 2 van der Wal WM, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, Geskus RB (2010) Comparing mortality in renal patients on hemodialysis versus peritoneal dialysis using a marginal structural model. Int J Biostat 6(1):Article 2
25.
go back to reference Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K (2013) Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol CJASN 8(4):619–628. doi:10.2215/CJN.04810512 CrossRef Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K (2013) Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol CJASN 8(4):619–628. doi:10.​2215/​CJN.​04810512 CrossRef
26.
go back to reference Collins AJ, Weinhandl E, Snyder JJ, Chen SC, Gilbertson D (2002) Comparison and survival of hemodialysis and peritoneal dialysis in the elderly. Semin Dial 15(2):98–102PubMedCrossRef Collins AJ, Weinhandl E, Snyder JJ, Chen SC, Gilbertson D (2002) Comparison and survival of hemodialysis and peritoneal dialysis in the elderly. Semin Dial 15(2):98–102PubMedCrossRef
27.
go back to reference Tam P (2009) Peritoneal dialysis and preservation of residual renal function. Perit Dial Int J Int Soc Perit Dial 29(Suppl 2):S108–S110 Tam P (2009) Peritoneal dialysis and preservation of residual renal function. Perit Dial Int J Int Soc Perit Dial 29(Suppl 2):S108–S110
28.
go back to reference Bloembergen WE, Port FK, Mauger EA, Wolfe RA (1995) A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol JASN 6(2):184–191 Bloembergen WE, Port FK, Mauger EA, Wolfe RA (1995) A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol JASN 6(2):184–191
30.
go back to reference Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ (2010) Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol JASN 21(3):499–506. doi:10.1681/ASN.2009060635 CrossRef Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ (2010) Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol JASN 21(3):499–506. doi:10.​1681/​ASN.​2009060635 CrossRef
32.
go back to reference de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA J Am Med Assoc 302(16):1782–1789. doi:10.1001/jama 2009.1488CrossRef de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA J Am Med Assoc 302(16):1782–1789. doi:10.​1001/​jama 2009.1488CrossRef
33.
go back to reference Spiegel BM, Bolus R, Desai AA, Zager P, Parker T, Moran J, Bolus S, Solomon MD, Khawar O, Gitlin M, Sul H, Talley J, Nissenson A (2010) Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomes. Am J Kidney Dis Off J Natl Kidney Found 56(1):86–94. doi:10.1053/j.ajkd.2010.02.346 CrossRef Spiegel BM, Bolus R, Desai AA, Zager P, Parker T, Moran J, Bolus S, Solomon MD, Khawar O, Gitlin M, Sul H, Talley J, Nissenson A (2010) Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomes. Am J Kidney Dis Off J Natl Kidney Found 56(1):86–94. doi:10.​1053/​j.​ajkd.​2010.​02.​346 CrossRef
Metadata
Title
Outcomes of dialytic modalities in a large incident registry cohort from Eastern Europe: the Romanian Renal Registry
Authors
Gabriel Mircescu
Gabriel Ştefan
Liliana Gârneaţă
Irina Mititiuc
Dimitrie Siriopol
Adrian Covic
Publication date
01-02-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0571-3

Other articles of this Issue 2/2014

International Urology and Nephrology 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine